C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 261/02 (2006.01) A61K 31/42 (2006.01) A61K 31/44 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61K 31/675 (2006.01) C07D 265/10 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07F 9/6527 (2006.01) C07F 9/6574 (2006.01)
Patent
CA 2263311
This invention relates generally to cyclic carbamates and hydroxylamines which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.
L'invention porte d'une manière générale sur des carbamates et sur des hydroxylamines cycliques servant d'antagonistes du complexe récepteur de fibrinogène de la glycoprotéine plaquettaire IIB/IIIA, sur des préparations pharmaceutiques contenant lesdits composés, sur leur procédé de préparation et sur des procédés d'utilisation de ces composés pour empêcher l'agrégation plaquettaire, sur leur utilisation comme thrombolytiques et/ou pour le traitement de troubles d'ordre thromboemboliques.
Confalone Pasquale Nicholas
Jin Fuqiang
Dimock Stratton Clarizio Llp
Du Pont Pharmaceuticals Company
LandOfFree
Cyclic carbamates and isoxazolidines as iib/iiia antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic carbamates and isoxazolidines as iib/iiia antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic carbamates and isoxazolidines as iib/iiia antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1642913